CVCasey Vieni

Casey Vieni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Casey Vieni has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply

    by Emilie A. Jochumsen, Jansen R. Seheult, Samantha Ngamsuntikul, Audra Taylor, Ulrik Sprogøe, Casey Vieni, Mark H. Yazer

    Background: Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA‐antibody screening was implemented in different strategies. Methods: Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA‐antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA‐antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD‐negative and RhD‐positive donors. Results: The model calculated that there would be 222,239 RhD‐negative male and 74,655 nulliparous RhD‐negative female donors. If all group O RhD‐negative parous females were screened, 109,479 were calculated to not be HLA‐sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD‐negative females ≥50 years were screened, 59,138 donors would not be HLA‐sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD‐negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA‐sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD‐positive males and females were modeled. Conclusion: HLA‐antibody screening realizes additional LTOWB donors.

  • Open Access

    Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion

    by Adnan S. Syed, Jansen R. Seheult, Casey Vieni, Steven G. Schauer, Randall Schaefer, Matthew J. Levy, Mark H. Yazer

    Background: As prehospital transfusion becomes more common in the United States (US), cases of hemolytic disease of the fetus and newborn (HDFN) might increase. This study forecasted the number of HDFN cases in 2029 resulting from RhD‐positive prehospital transfusions. Study Design and Methods: A regression was performed on the number of females of childbearing potential (FCP) who received RhD‐positive prehospital transfusions between 2020 and 2024 in the US to forecast the total number of FCPs who would receive transfusions in 2029. Then, a model using current nativity and population demographics was used to calculate the regional rate of HDFN in 2029 (Model 1). In addition, the frequency of transfusing FCPs in the four US census regions in 2029 was varied based upon the regional uptake of prehospital low titer group O whole blood transfusion between 2024 and 2025 (Model 2) and the uptake of prehospital transfusion by ground ambulances between 2019 and 2026 (Model 3). Each model was instantiated 500 times. Results: It was forecasted that 779 FCPs would receive prehospital transfusions in 2029 throughout the US. In Model 1, the number of years required for one case of HDFN to occur was calculated to range from 0.5 (South)–20.0 (Northeast). When the regional frequency of providing prehospital transfusions was varied, the number of years required for one case of HDFN to occur ranged from 0.6 (South)–13.5 (Northeast) (Model 2), and between 0.7 (South)–4.6 (Northeast) (Model 3). Discussion: As prehospital transfusions increase, the risk of HDFN is predicted to also increase.

  • Open Access

    A stochastic, physiology-based digital twin model of hemostasis and oxygenation in trauma resuscitation

    by Casey Vieni, Anika Iftekharuddin, Kevin Ward, Roland Pittman, Andrew Norgan, Matthew Neal, Darrell Triulzi, Phillip Spinella, Jason Sperry, Mark Yazer, et al.

    Hemorrhagic shock is a common emergency that accounts for more than 10% of global mortality and up to 40% of trauma-related mortality. The Advanced Trauma Life Support (ATLS) guidelines outline resuscitation strategies in patients with massive hemorrhage based on clinical trial and observational data. Early intervention with fluids and/or blood products is recommended during resuscitation as key to maintaining vascular patency, stabilizing a patient’s blood pressure, maintaining tissue oxygenation, and limiting shock. From a transfusion perspective, there is wide heterogeneity in the quality of blood products due to donor and manufacturing variation. The optimal transfusion strategy for massive hemorrhage remains unclear. In silico models of resuscitation may offer a means to evaluate the effectiveness and safety of various resuscitation protocols. Here we describe a stochastic multicompartment model of fluid balance and resuscitation that includes (i) cardiovascular hemodynamics, (ii) body fluid compartments and capillary solute exchange, (iii) the ability to alter hemorrhage, resuscitation, and hemostasis parameters, and (iv) tissue oxygenation and capillary-alveolar gas exchange. Building upon deterministic frameworks, this stochastic model more faithfully reflects the clinical heterogeneity of bleeding patients at a level I trauma center. This allows for a proof of concept in silico trial comparing crystalloids, conventional component therapy (CCT), i.e. red cell, platelet and plasma components, to cold-stored low titer group O whole blood (LTOWB). In an in silico cohort of ATLS class III (>30% and ≤40% blood volume lost) hemorrhage, LTOWB resuscitation reduced the time spent in the critical hemostatic window (platelet count 10% or SBP > 150% of the starting SBP, or Hgb < 3.0 g/dL). In a separate cohort of ATLS class IV (>40% blood volume lost) hemorrhage, LTOWB yielded a higher predicted event-free survival (74%) versus the CCT arm (69%, p < 0.01). We demonstrate how this in silico platform can function as a digital twin for hemorrhagic trauma enabling precision transfusion strategies, and in parallel, an operational twin to support blood banks to forecast blood product demand and inform massive transfusion protocols and clinical trial design.

  • Open Access

    Comparison of blood culture contamination rates with standard practice versus two blood diversion devices at a single institution

    by Casey Vieni, Michele Legried, Jill Mainella, Kelly Bute, Linda Backus, Priya Sampathkumar, Audrey N. Schuetz, Robin Patel, Brad S. Karon

    Blood culture contamination can lead to false-positive blood culture results, potentially contributing to increased costs and unneeded antibiotic utilization. Initial specimen diversion devices (ISDD) have been proposed to reduce blood culture contamination rates. A single-center, observational study conducted at Mayo Clinic Rochester compared blood culture contamination rates using Steripath or Kurin ISDDs versus standard blood culture collection protocols. Over 255 phlebotomists were trained in the use of the ISDDs, with 31,215 blood cultures, 410 of which were contaminated, collected from adults in the emergency department and inpatient wards. Baseline contamination rates were 1.29%–2.53% with standard collection methods. The Steripath ISDD with direct-to-media inoculation of blood culture bottles (Steripath-DTM) reduced blood culture contamination compared to standard practice (0.34% vs. 1.43%, respectively, P < 0.001). Follow-up studies with the alternative Steripath configuration with an integrated syringe (Steripath-syringe), and then the Kurin ISDD with syringe collection (Kurin-syringe), did not meet the primary endpoint of 75% utilization, with an average measured utilization of 26% for the Steripath-DTM, 26.4% for the Steripath ISDD (combined DTM and syringe) in a follow-up study, and 41.5% in the Kurin study. Additionally, a survey of phlebotomists revealed low staff satisfaction with both Steripath ISDD configurations. Staff reported multiple ergonomic barriers limiting the Steripath ISDD’s utility, which precluded implementation of the Steripath-DTM in routine clinical practice. IMPORTANCE: We conducted a very large, real-world study of two blood diversion devices to determine whether either would meet goals for reduced blood culture contamination and a high rate of utilization by phlebotomists.


  • Open Access

    Role of Ring6 in the function of the E. coli MCE protein LetB

    by Casey Vieni, Nicolas Coudray, Georgia L. Isom, Gira Bhabha, Damian C. Ekiert

    LetB is a tunnel-forming protein found in the cell envelope of some double-membraned bacteria, and is thought to be important for the transport of lipids between the inner and outer membranes. In Escherichia coli the LetB tunnel is formed from a stack of seven rings (Ring1 - Ring7), in which each ring is composed of a homo-hexameric assembly of MCE domains. The primary sequence of each MCE domain of the LetB protein is substantially divergent from the others, making each MCE ring unique in nature. The role of each MCE domain and how it contributes to the function of LetB is not well understood. Here we probed the importance of each MCE ring for the function of LetB, using a combination of bacterial growth assays and cryo-EM. Surprisingly, we find that ΔRing3 and ΔRing6 mutants, in which Ring3 and Ring6 have been deleted, confer increased resistance to membrane perturbing agents. Specific mutations in the pore-lining loops of Ring6 similarly confer increased resistance. A cryo-EM structure of the ΔRing6 mutant shows that despite the absence of Ring6, which leads to a shorter assembly, the overall architecture is maintained, highlighting the modular nature of MCE proteins. Previous work has shown that Ring6 is dynamic and in its closed state, may restrict the passage of substrate through the tunnel. Our work suggests that removal of Ring6 may relieve this restriction. The deletion of Ring6 combined with mutations in the pore-lining loops leads to a model for the tunnel gating mechanism of LetB. Together, these results provide insight into the functional roles of individual MCE domains and pore-lining loops in the LetB protein. Highlights: Deleting MCE domains 3 or 6 from LetB confers increased resistance to membrane-perturbing agents Cryo-EM structure of ΔRing6 LetB mutant highlights the modular nature of MCE domains Mutations along LetB pore-lining loops modulate detergent resistance

  • Open Access

    Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis

    by Miriam L. Fichtner, Casey Vieni, Rachel L. Redler, Ljuvica Kolich, Ruoyi Jiang, Kazushiro Takata, Panos Stathopoulos, Pablo A. Suarez, Richard J. Nowak, Steven J. Burden, et al.

    Pathogenic muscle-specific tyrosine kinase (MuSK)–specific IgG4 autoantibodies in autoimmune myasthenia gravis (MG) are functionally monovalent as a result of Fab-arm exchange. The development of these unique autoantibodies is not well understood. We examined MG patient–derived monoclonal autoantibodies (mAbs), their corresponding germline-encoded unmutated common ancestors (UCAs), and monovalent antigen-binding fragments (Fabs) to investigate how affinity maturation contributes to binding and immunopathology. Mature mAbs, UCA mAbs, and mature monovalent Fabs bound to MuSK and demonstrated pathogenic capacity. However, monovalent UCA Fabs bound to MuSK but did not have measurable pathogenic capacity. Affinity of the UCA Fabs for MuSK was 100-fold lower than the subnanomolar affinity of the mature Fabs. Crystal structures of two Fabs revealed how mutations acquired during affinity maturation may contribute to increased MuSK-binding affinity. These findings indicate that the autoantigen drives autoimmunity in MuSK MG through the accumulation of somatic mutations such that monovalent IgG4 Fab-arm–exchanged autoantibodies reach a high-affinity threshold required for pathogenic capacity.


  • Open Access

    Self-antigen driven affinity maturation is required for pathogenic monovalent IgG4 autoantibody development

    by Miriam L. Fichtner, Casey Vieni, Rachel L. Redler, Ljuvica Kolich, Ruoyi Jiang, Kazushiro Takata, Panos Stathopoulos, Pablo Suarez, Richard J. Nowak, Steven J. Burden, et al.

    Pathogenic IgG4 autoantibodies in autoimmune myasthenia gravis (MG) are functionally monovalent as a result of Fab-arm exchange. The origin and development of these unique autoantibodies are not well understood. We examined MG patient-derived monoclonal autoantibodies (mAbs), their corresponding germline-encoded unmutated common ancestors (UCA) and monovalent antigen-binding fragments (Fabs) to investigate how antigen-driven affinity maturation contributes to both binding and immunopathology. Mature mAbs, their UCA counterparts and mature monovalent Fabs bound to the autoantigen and retained their pathogenic capacity. However, monovalent UCA Fabs still bound the autoantigen but lost their pathogenic capacity. The mature Fabs were characterized by very high affinity (sub-nanomolar) driven by a rapid on-rate and slow off-rate. However, the UCA affinity was approximately 100-fold less than that of the mature Fabs, which was driven by a rapid off-rate. Crystal structures of two Fabs shed light on how mutations acquired during affinity maturation may contribute to increased MuSK binding affinity. These collective findings indicate that the autoantigen initiates the autoimmune response in MuSK MG and drives autoimmunity through the accumulation of somatic hypermutation such that monovalent IgG4 Fab-arm exchanged MG autoantibodies reach a high affinity threshold required for pathogenic capacity. Summary: IgG4 autoantibodies in autoimmune myasthenia gravis are functionally monovalent, requiring a high affinity threshold featuring fast on/slow off rates, to reach pathogenic capacity. This capacity is dependent on self-antigen initiated and driven maturation, which includes the accumulation of indispensable somatic hypermutations that may alter electrostatic interactions with the antigen.


  • Open Access

    Effect of intravoxel incoherent motion on diffusion parameters in normal brain

    by Casey Vieni, Benjamin Ades-Aron, Bettina Conti, Eric E. Sigmund, Peter Riviello, Timothy M. Shepherd, Yvonne W. Lui, Dmitry S. Novikov, Els Fieremans